Literature DB >> 22228566

Activity of childhood lupus nephritis is linked to altered T cell and cytokine homeostasis.

Monika Edelbauer1, Sudhir Kshirsagar, Magdalena Riedl, Heiko Billing, Burkhard Tönshoff, Dieter Haffner, Gerard Cortina, Oliver Amon, Sophia Ross, Jörg Dötsch, Gottfried Wechselberger, Lutz T Weber, Martin Dablander, Markus Anliker, Andrea Griesmacher, Elisabeth Steichen-Gersdorf.   

Abstract

PURPOSE: Standard therapy for lupus nephritis is based on non-specific immunosuppression. We aimed to identify specific alterations in T cell and cytokine homeostasis and possible associations with disease activity in children with lupus nephritis (LN).
METHODS: The phenotype of circulating T cells from children with LN and healthy controls (HC) was analyzed by flow cytometry. Intracellular expression of IL-17 and INF-γ was assessed after stimulation with anti-CD3 and anti-CD28. Serum concentrations of IP10, CCL2, TGF-β, IL-17, and IL-23 were measured by ELISA. Disease activity was determined using the Systemic Lupus Erythematosus Disease Activity Index 2000 update (SLEDAI-2K).
RESULTS: Children with active LN displayed increased frequencies of effector memory CD4(+)CD45RO(+)CCR7(-) and terminal differentiated CD4(+)CD45RA(+)CCR7(-) T cells and reduced naive CD4(+)CD45RA(+)CCR7(+) T cells compared to those with inactive LN or HC. Circulating CD4(+)CXCR3(+) and CD4(+)CCR2(+) T cells correlated inversely with the renal SLEDAI-2K, whereas IP10 and CCL2 showed a positive correlation. Reduced CD4(+)Foxp3(+) T cells and serum TFG-β levels in active LN were associated with high serum IL-17 and IL-23 levels and correlated inversely with the renal SLEDAI-2K (r = -0.5855, p = 0.0013 and r = -0.6246, p = 0.0005, respectively), whereas IL-17 and IL-23 correlated positively (r = 0.5516, p = 0.0029 and r = 0.6116, p = 0.0007, respectively). Expansion of Th17 and Th1/Th17 cells in children with LN was significantly greater than in HC (p = 0.0304 and p = 0.0067, respectively).
CONCLUSION: Children with active LN display high levels of pro-inflammatory cytokines associated with an increase in effector T cells and reduction of regulatory T cells. Therapeutic regulation of the aberrant cytokine profile might specifically interrupt pathogenic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22228566     DOI: 10.1007/s10875-011-9637-0

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  33 in total

1.  Generalized multi-organ autoimmunity in CCR7-deficient mice.

Authors:  Ana C M Davalos-Misslitz; Julia Rieckenberg; Stefanie Willenzon; Tim Worbs; Elisabeth Kremmer; Günter Bernhardt; Reinhold Förster
Journal:  Eur J Immunol       Date:  2007-03       Impact factor: 5.532

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 3.  Th1 and Th17 cells: adversaries and collaborators.

Authors:  Jesse M Damsker; Anna M Hansen; Rachel R Caspi
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

4.  Outcome after transplantation of young patients with systemic lupus erythematosus: a report of the North American pediatric renal transplant cooperative study.

Authors:  S M Bartosh; R N Fine; E K Sullivan
Journal:  Transplantation       Date:  2001-09-15       Impact factor: 4.939

5.  OX40 costimulation turns off Foxp3+ Tregs.

Authors:  Minh Diem Vu; Xiang Xiao; Wenda Gao; Nicolas Degauque; Ming Chen; Alexander Kroemer; Nigel Killeen; Naoto Ishii; Xian Chang Li
Journal:  Blood       Date:  2007-06-15       Impact factor: 22.113

6.  Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus.

Authors:  Jens Y Humrich; Henner Morbach; Reinmar Undeutsch; Philipp Enghard; Stefan Rosenberger; Olivia Weigert; Lutz Kloke; Juliane Heimann; Timo Gaber; Susan Brandenburg; Alexander Scheffold; Jochen Huehn; Andreas Radbruch; Gerd-Rüdiger Burmester; Gabriela Riemekasten
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

Review 7.  The busy life of regulatory T cells in systemic lupus erythematosus.

Authors:  Antonio La Cava
Journal:  Discov Med       Date:  2009-06       Impact factor: 2.970

8.  The role of IL-23/IL-17 axis in lupus nephritis.

Authors:  Zheng Zhang; Vasileios C Kyttaris; George C Tsokos
Journal:  J Immunol       Date:  2009-08-05       Impact factor: 5.422

9.  CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.

Authors:  Oliver M Steinmetz; Jan-Eric Turner; Hans-Joachim Paust; Matthias Lindner; Anett Peters; Kirstin Heiss; Joachim Velden; Helmut Hopfer; Susanne Fehr; Thorsten Krieger; Catherine Meyer-Schwesinger; Tobias N Meyer; Udo Helmchen; Hans-Willi Mittrücker; Rolf A K Stahl; Ulf Panzer
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

Review 10.  Chemokines in lupus nephritis.

Authors:  Onkar Kulkarni; Hans-Joachim Anders
Journal:  Front Biosci       Date:  2008-05-01
View more
  14 in total

1.  Regulatory T cell subsets in children with systemic lupus erythematosus.

Authors:  Azza A Eltayeb; Douaa M Sayed; Noha A Afifi; Maggie A Ibrahim; Tahra M Sheref
Journal:  Clin Rheumatol       Date:  2014-05-27       Impact factor: 2.980

2.  Clinical and laboratorial outcome of different age-onset systemic lupus erythematosus patients in Jiangsu, China: a multicentre retrospective study.

Authors:  Lihui Wen; Ziyan Chen; Ziyi Jin; Wenyou Pan; Lin Liu; Min Wu; Fuwan Ding; Huaixia Hu; Xiang Ding; Hua Wei; Yaohong Zou; Xian Qian; Meimei Wang; Jian Wu; Juan Tao; Jun Tan; Zhanyun Da; Miaojia Zhang; Jing Li; Xuebing Feng; Jun Liang; Huayong Zhang; Lingyun Sun
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

Review 3.  CD8+ T-Cells in Juvenile-Onset SLE: From Pathogenesis to Comorbidities.

Authors:  Coziana Ciurtin; Ines Pineda-Torra; Elizabeth C Jury; George A Robinson
Journal:  Front Med (Lausanne)       Date:  2022-06-21

Review 4.  Biomarkers and updates on pediatrics lupus nephritis.

Authors:  Michael Bennett; Hermine I Brunner
Journal:  Rheum Dis Clin North Am       Date:  2013-07-16       Impact factor: 2.670

5.  Premature T Cell Senescence in Pediatric CKD.

Authors:  Roshan P George; Aneesh K Mehta; Sebastian D Perez; Pamela Winterberg; Jennifer Cheeseman; Brandi Johnson; Jean Kwun; Stephanie Monday; Linda Stempora; Barry Warshaw; Allan D Kirk
Journal:  J Am Soc Nephrol       Date:  2016-07-13       Impact factor: 10.121

6.  The parasitic worm product ES-62 targets myeloid differentiation factor 88-dependent effector mechanisms to suppress antinuclear antibody production and proteinuria in MRL/lpr mice.

Authors:  David T Rodgers; Mairi A McGrath; Miguel A Pineda; Lamyaa Al-Riyami; Justyna Rzepecka; Felicity Lumb; William Harnett; Margaret M Harnett
Journal:  Arthritis Rheumatol       Date:  2015-04       Impact factor: 10.995

7.  Cytokine profile in childhood-onset systemic lupus erythematosus: a cross-sectional and longitudinal study.

Authors:  A Cavalcanti; R Santos; Z Mesquita; A L B P Duarte; N Lucena-Silva
Journal:  Braz J Med Biol Res       Date:  2017-04-03       Impact factor: 2.590

Review 8.  Chemokines as potential markers in pediatric renal diseases.

Authors:  Ana Cristina Simões e Silva; André Barreto Pereira; Mauro Martins Teixeira; Antônio Lúcio Teixeira
Journal:  Dis Markers       Date:  2014-02-17       Impact factor: 3.434

9.  The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus.

Authors:  Lucy E Ballantine; Joanne Ong; Angela Midgley; Louise Watson; Brian F Flanagan; Michael W Beresford
Journal:  Pediatr Rheumatol Online J       Date:  2014-01-16       Impact factor: 3.054

Review 10.  Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus.

Authors:  Takayuki Katsuyama; George C Tsokos; Vaishali R Moulton
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.